APREPITANT RMB aprepitant 80 mg capsule blister pack

País: Austrália

Língua: inglês

Origem: Department of Health (Therapeutic Goods Administration)

Ingredientes ativos:

aprepitant, Quantity: 80 mg

Disponível em:

Southern Cross Pharma Pty Ltd

Forma farmacêutica:

Capsule, hard

Composição:

Excipient Ingredients: poloxamer; Gelatin; microcrystalline cellulose; hypromellose; sucrose; titanium dioxide; sodium lauryl sulfate; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; Shellac; sulfuric acid

Via de administração:

Oral

Unidades em pacote:

1 and 2

Tipo de prescrição:

(S4) Prescription Only Medicine

Indicações terapêuticas:

Aprepitant in combination with other antiemetic agents, is indicated for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of:,? highly emetogenic cancer chemotherapy.,? moderately emetogenic cancer chemotherapy,Aprepitant is indicated for the prevention of postoperative nausea and vomiting.

Resumo do produto:

Visual Identification: opaque hard gelatin capsules with a white cap and white body, printed with 80mg on the body; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius

Status de autorização:

Registered

Data de autorização:

2019-07-03